Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › HLA-A24 binding cancer antigen peptide derived from livin

HLA-A24 binding cancer antigen peptide derived from livin

US Patent 7601801 · Granted Oct 13, 2009

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method and reagent for quantifying cholesterol in high density lipoprotein 32024
Molecular marker for cancer stem cell2022
Molecular marker for cancer stem cell2022
Method and reagent for quantifying cholesterol in high density lipoprotein 32021
Tumor antigen peptide2021
Tumor antigen peptide2021
Tumor antigen peptide2021
Tumor antigen peptide2020
Tumor antigen peptide2020
Tumor antigen peptide2020
Molecular marker for cancer stem cell2018
Molecular marker for cancer stem cell2018